- Home
- ESCA vs CRVO Comparison
ESCA vs CRVO Comparison
Compare ESCA & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESCA
- CRVO
- Stock Information
- Founded
- ESCA 1922
- CRVO 2001
- Country
- ESCA United States
- CRVO United States
- Employees
- ESCA N/A
- CRVO N/A
- Industry
- ESCA Recreational Games/Products/Toys
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- ESCA Consumer Discretionary
- CRVO Health Care
- Exchange
- ESCA Nasdaq
- CRVO Nasdaq
- Market Cap
- ESCA 194.0M
- CRVO 160.4M
- IPO Year
- ESCA N/A
- CRVO N/A
- Fundamental
- Price
- ESCA $14.39
- CRVO $10.77
- Analyst Decision
- ESCA
- CRVO Strong Buy
- Analyst Count
- ESCA 0
- CRVO 5
- Target Price
- ESCA N/A
- CRVO $57.60
- AVG Volume (30 Days)
- ESCA 23.3K
- CRVO 81.9K
- Earning Date
- ESCA 10-24-2024
- CRVO 11-12-2024
- Dividend Yield
- ESCA 4.17%
- CRVO N/A
- EPS Growth
- ESCA 35.81
- CRVO N/A
- EPS
- ESCA 0.94
- CRVO N/A
- Revenue
- ESCA $253,074,000.00
- CRVO $10,066,550.00
- Revenue This Year
- ESCA N/A
- CRVO $54.67
- Revenue Next Year
- ESCA N/A
- CRVO N/A
- P/E Ratio
- ESCA $15.32
- CRVO N/A
- Revenue Growth
- ESCA N/A
- CRVO 116.29
- 52 Week Low
- ESCA $12.34
- CRVO $5.85
- 52 Week High
- ESCA $22.01
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- ESCA 53.64
- CRVO 33.46
- Support Level
- ESCA $14.29
- CRVO $11.95
- Resistance Level
- ESCA $14.80
- CRVO $12.35
- Average True Range (ATR)
- ESCA 0.50
- CRVO 1.04
- MACD
- ESCA 0.04
- CRVO -0.16
- Stochastic Oscillator
- ESCA 53.68
- CRVO 7.45
About ESCA Escalade Incorporated
Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting, and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.